|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | |
| C07K 1/00 | |||
| C12P 21/06 |
| (11) | Number of the document | 2874649 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13810018.5 |
| Date of filing the European patent application | 2013-06-28 | |
| (97) | Date of publication of the European application | 2015-05-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/048571 |
| Date | 2013-06-28 |
| (87) | Number | WO 2014/005019 |
| Date | 2014-01-03 |
| (30) | Number | Date | Country code |
| 201261666719 P | 2012-06-29 | US |
| (72) |
BOLDOG, Ferenc, US
HEARTLEIN, Michael, US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington MA 02421,
US
|
| (54) | CELLS FOR PRODUCING RECOMBINANT IDURONATE-2-SULFATASE |
| CELLS FOR PRODUCING RECOMBINANT IDURONATE-2-SULFATASE |